Pathogen detection

Choose your target and we’ll help you get a bull’s-eye.
Your partner for every pivot

Scale with ease as needs change.

The onset of the COVID-19 global pandemic in early 2020 marked the start of a dramatic pivot in clinical diagnostic assay development, and in patient sample collection and processing. As vaccination programmes roll out, diagnostic assay developers and testing labs need to remain vigilant in accommodating the evolving needs of the public health crisis as well as ongoing demand for patient screening for a wide breadth of conditions.

Throughout the COVID-19 pandemic, Biosearch Technologies demonstrated a unique ability to serve the diagnostic community as a reliable mission-critical component supplier. Explore how we can help your organisation manage today while planning for tomorrow.

Evolve your genomics with an evolving virus

COVID-19 resource hub


Customise our solutions to meet your specifications
We have the expertise to leverage our flexible manufacturing platform to deliver according to your specifications and throughput, yielding a product that produces repeatable and consistent performance. Our comprehensive portfolio grants our customers unparalleled freedom for customisation that’s coupled with a hands-on team to help bring your ideas and aspirations to life.